yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q35142705-8414E4D3-E12C-41A9-8091-90E322003CB0
Q35142705-8414E4D3-E12C-41A9-8091-90E322003CB0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35142705-8414E4D3-E12C-41A9-8091-90E322003CB0
Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair.
P2860
Q35142705-8414E4D3-E12C-41A9-8091-90E322003CB0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35142705-8414E4D3-E12C-41A9-8091-90E322003CB0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7b7f8df8ed35d3b4865ff967b128c392ac72571a
P2860
Nimotuzumab: a novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity.